Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through...
94 insider purchases on record · latest filing 2025-05-19.
Insiders have also filed 112 sale transactions at FENC.